Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV/HCV Coinfection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Not applicableStudy completedNCT00747539
What this trial is testing

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

Who this might be right for
HIVHepatitis CInfections
University of California, Los Angeles 330
Post-approval studies (Phase 4)UnknownNCT00611819
What this trial is testing

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Who this might be right for
Chronic Hepatitis CCo-Infection HIV-HCV
University of Valencia 59
Large-scale testing (Phase 3)Study completedNCT00190242
What this trial is testing

Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients

Who this might be right for
HIV Infection
Assistance Publique - Hôpitaux de Paris 99
Large-scale testing (Phase 3)Study completedNCT01513941
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Chronic Hepatitis C
Janssen-Cilag International NV 163
Not applicableUnknownNCT04768517
What this trial is testing

HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus (HIV) Coinfection
National Taiwan University Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02457611
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection

Who this might be right for
Hepatitis C Infection With HIV Co-Infection
Gilead Sciences 26
Not applicableStudy completedNCT01335230
What this trial is testing

The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients

Who this might be right for
HIVHepatitis C, ChronicHCV Coinfection
University of Cincinnati 40
Testing effectiveness (Phase 2)Ended earlyNCT00158535
What this trial is testing

Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection

Who this might be right for
HIV InfectionsHepatitis C
ANRS, Emerging Infectious Diseases 15
Post-approval studies (Phase 4)Study completedNCT01222611
What this trial is testing

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Who this might be right for
Chronic HIV InfectionHCV Coinfection
Fundacion SEIMC-GESIDA 42
Large-scale testing (Phase 3)Ended earlyNCT02762383
What this trial is testing

Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)

Who this might be right for
HIV/HCV Coinfection
Hoffmann-La Roche 19
Not applicableStudy completedNCT03401697
What this trial is testing

Eliminating Hepatitis C Virus

Who this might be right for
Hepatitis CHIVType2 Diabetes
Icahn School of Medicine at Mount Sinai 52
Testing effectiveness (Phase 2)Study completedNCT02480387
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection

Who this might be right for
Treatment of Hepatitis C
Peter J. Ruane, M.D., Inc. 20
Post-approval studies (Phase 4)Study completedNCT01900015
What this trial is testing

Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection

Who this might be right for
HCV CoinfectionHIV Infection
Juan Macías 45
Early research (Phase 1)Study completedNCT00545558
What this trial is testing

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Who this might be right for
Hepatitis CHIV Infections
University of Cincinnati 18
Testing effectiveness (Phase 2)Study completedNCT01231685
What this trial is testing

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Who this might be right for
HIVHepatitis CLiver Fibrosis
McGill University Health Centre/Research Institute of the McGill University Health Centre 9
Testing effectiveness (Phase 2)Study completedNCT00059358
What this trial is testing

Zidovudine Levels in HIV Infected Patients Being Treated for HCV

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 16
Post-approval studies (Phase 4)Study completedNCT00356486
What this trial is testing

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 74
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Next Page